Invenire Partners, LP Sensus Healthcare, Inc. Transaction History
Invenire Partners, LP
- $65.3 Million
- Q3 2022
A detailed history of Invenire Partners, LP transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Invenire Partners, LP holds 118,867 shares of SRTS stock, worth $924,785. This represents 100.0% of its overall portfolio holdings.
Number of Shares
118,867Holding current value
$924,785% of portfolio
100.0%Shares
1 transactions
Others Institutions Holding SRTS
# of Institutions
55Shares Held
3.88MCall Options Held
24.9KPut Options Held
800-
Vanguard Group Inc Valley Forge, PA779KShares$6.06 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny409KShares$3.18 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA304KShares$2.36 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX290KShares$2.25 Million0.0% of portfolio
-
Morgan Stanley New York, NY185KShares$1.44 Million0.0% of portfolio
About Sensus Healthcare, Inc.
- Ticker SRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,556,000
- Market Cap $129M
- Description
- Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...